OSX Stock Overview
A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Osteopore Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.061 |
| 52 Week High | AU$2.17 |
| 52 Week Low | AU$0.04 |
| Beta | 0.40 |
| 1 Month Change | -83.73% |
| 3 Month Change | -86.59% |
| 1 Year Change | -94.79% |
| 3 Year Change | -99.12% |
| 5 Year Change | n/a |
| Change since IPO | -99.44% |
Recent News & Updates
Shareholder Returns
| OSX | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -15.3% | -0.03% | -1.0% |
| 1Y | -94.8% | 14.9% | 8.4% |
Return vs Industry: OSX underperformed the Australian Medical Equipment industry which returned 14.9% over the past year.
Return vs Market: OSX underperformed the Australian Market which returned 8.4% over the past year.
Price Volatility
| OSX volatility | |
|---|---|
| OSX Average Weekly Movement | 135.9% |
| Medical Equipment Industry Average Movement | 10.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: OSX's share price has been volatile over the past 3 months.
Volatility Over Time: OSX's weekly volatility has increased from 66% to 136% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Yujing Lim | www.osteopore.com |
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.
Osteopore Limited Fundamentals Summary
| OSX fundamental statistics | |
|---|---|
| Market cap | AU$6.93m |
| Earnings (TTM) | -AU$4.87m |
| Revenue (TTM) | AU$2.22m |
3.1x
P/S Ratio-1.4x
P/E RatioIs OSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSX income statement (TTM) | |
|---|---|
| Revenue | AU$2.22m |
| Cost of Revenue | AU$581.51k |
| Gross Profit | AU$1.64m |
| Other Expenses | AU$6.51m |
| Earnings | -AU$4.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.043 |
| Gross Margin | 73.78% |
| Net Profit Margin | -219.72% |
| Debt/Equity Ratio | 246.0% |
How did OSX perform over the long term?
See historical performance and comparison